Shire PLC (SHP) PT Lowered to GBX 6,200

Shire PLC (SHP) PT Lowered to GBX 6,200


The firm currently has a "buy" rating on the biopharmaceutical company's stock. Societe Generale's price target points to a potential upside of 26.78% from the company's current price.



from Biotech News